Title : [Medical treatment of Alzheimer's disease].

Pub. Date : 2006 Oct 2

PMID : 17032609






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Three cholinesterase inhibitors (donepezil, rivastigmin og galantamin) are approved mild to moderate Alzheimer"s disease and one partial NMDA receptor antagonist (memantin) with the indication moderate to severe Alzheimer"s disease. Galantamine butyrylcholinesterase Homo sapiens